Our agenda and speakers

Welcome

Elizabeth Jaffee, Johns Hopkins University School of Medicine

09:55 – 10:40

Keynote address
Chair: Elizabeth Jaffee, Johns Hopkins University School of Medicine
Speaker: Allan Balmain, University of California San Francisco

Pre-cancer biology & interception opportunities
Co-chairs:

Irene Ghobrial, Harvard Medical School 
Simon Leedham, University of Oxford 

Speakers: 

Margarete Fabre, AstraZeneca and Cambridge University Hospitals NHS Trust
Irene Ghobrial, Harvard Medical School

“Interception opportunities for preneoplastic lesions of pancreatic cancer”
Jen Morton, Cancer Research UK Scotland Institute

“Clonal biases in intestinal epithelium dictate the transformation landscape”
Doug Winton, Cambridge Stem Cell Institute

Emerging researchers’ flash talks
Talks will be selected from abstracts

Panel session: immune system insights: the role of immune dysfunction in cancer development and prevention 

Chair: Tim Elliott, Cancer Research UK Oxford Centre  

Speakers: 
Lisa Coussens, OHSU, Knight Cancer Institute
Olivera Finn, University of Pittsburgh
Rahul Roychoudhuri, University of Cambridge
Ruth Travis, University of Oxford

Integrated view of inequalities in cancer risk and incidence; how to achieve equitable cancer prevention?
Co-chairs:

Melissa Davis, Morehouse School of Medicine
Neerja Bhatla, AIIMS (All India Institute of Medical Sciences, New Delhi)

Speakers:

Nyasha Chambwe, Feinstein Institutes for Medical Research 

Carla Chibwesha, University of North Carolina 

Lauren McCullough, Emory University

“Tobacco is the New Tobacco: Global effects of smoking, quitting and taxing tobacco”
Prabhat Jha, University of Toronto

08:15 – 08:50

Light breakfast

08:50 – 09:00

Opening remarks

Sarah Blagden, University of Oxford 

09:00 – 09:45

Keynote address

Chair: Sarah Blagden, University of Oxford 

Speaker: Sir John Burn, Newcastle University

09:45 – 10:10

Emerging researchers’ flash talks
Talks will be selected from abstracts

10:10 – 10:40

Networking break and exhibition

10:40 – 12:40

The convergence of ageing, genetics and cancer risk/genesis; new opportunities for prevention

Co-chairs:

Walid Khaled, Cambridge Stem Cell Institute
Ashani Weeraratna, John Hopkins 

Speakers:

Alex Cagan, University of Cambridge

“Dissecting and targeting (onco)gene-environment interactions driving pancreatic cancer initiation”
Direna Alonso, Institute for Research in Biomedicine

“Age-related stromal changes drive breast cancer progression”
Sheila Stewart, Washington University School of Medicine

“Intersection of tumorigenesis and aging-associated decline in lung regenerative potential”
Tuomas Tammela, Memorial Sloan Kettering Cancer Center

12:40 – 13:50

Lunch, exhibition and poster viewing

13:50  - 14:35

Panel session: defining the Pre-Cancer State to enable innovations in preventive intervention
Chair: Laura Wood, Johns Hopkins University School of Medicine

Speakers: Sam Janes, University College London
Marnix Jansen, UCL Cancer Institute
Phil Jones, University of Cambridge
Kit Curtius, University of California San Diego 

14:40 – 15:15

Debate: cancer prevention research should focus on understanding cancer risk, genesis and targets in
childhood and adolescence - waiting until late adulthood when risk is highest is too late to effectively prevent.

Chair: David Crosby, Cancer Research UK
For the motion: Yin Cao, Washington University School of Medicine
Against the motion: Annie Anderson, University of Dundee

15:15 – 15:45

Networking break and exhibition

15:45 – 16:45

Panel session: defining high-risk in cancer prevention: a patient and public perspective

Moderator: William Dahut, Chief Scientific Officer, American Cancer Society (ACS)
Speakers: Carole Baas, Patient Advocate
Emma Crosbie, University of Manchester
Anna Fry, Patient Advocate
Steph Phillips, Patient Advocate

16:45 – 17:00

Closing remarks and award presentations for “Outstanding Achievement in Cancer Prevention Research”

17:00 – 18:00

Networking drinks and poster session

18:30 – late

Networking dinner

SEA LIFE London Aquarium, Riverside Building, County Hall, Westminster Bridge Rd, London SE1 7PB 

08:30 – 09:00

Light breakfast

09:00 – 09:05

Opening remarks
Marc Gunter, Imperial College London

09:05 – 09:20

American Cancer Society Atlas launch

09:20 – 11:20

Implementation of precision prevention interventions using repurposed drugs - can this realistically change practice?  
Co-chairs:

Pamela Goodwin, Sinai Health
Eva Szabo, National Cancer Institute

Speakers:

Karen Brown, University of Leicester 

“Repurposing metformin for oral cancer precision prevention: Halting the malignant reprogramming of epithelial stem cells” 

J. Silvio Gutkind, University of California San Diego 

“Cancer therapy drugs in the preventive arena: optimizing dose & delivery”
Seema Khan, Northwestern Feinberg school of Medicine

Andrew Reynolds, Astra Zeneca  

11:20 – 11:50

Networking break and exhibition

11:50 – 12:10

Emerging researchers’ flash talks
Talks will be selected from abstracts

12:15 – 12:50

12:50 – 14:00

Lunch and exhibition

14:00 – 14:45

Panel session: can we ever really implement cancer prevention in the general population?

Chair: Linda Bauld, University of Edinburgh
Speakers: 
Susan Domchek, University of Pennsylvania
Susan Jebb OBE, University of Oxford
Richard Sullivan, Kings College London
Katie Tyron, Vitality Health

14:45 – 14:55

Comfort break

15:00 – 15:45

15:45 – 16:30

Keynote address
Chair: Marc Gunter, Imperial College London
Speaker: Elisabete Weiderpass, International Agency for Research on Cancer

16:30 – 16:50

Closing remarks and conference close